October 23, 2021

applebusiness

We Build Business

Zhongchao Inc. Announces Hematological Tumor Affected individual Administration Business to More Develop to Out-of-Medical center Marketplace

SHANGHAI, Sept. 10, 2021 /PRNewswire/ — Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Corporation”), an internet technological know-how firm supplying healthcare professionals the on the web health care details, expert teaching and educational companies platform and people the patient management platform, now declared its subsidiary Shanghai Zhongxin Medical Know-how Co., Ltd. (“Zhongxin”) launches Hematological Tumor Patient Care Middle (the “Care Heart”), continuing to boost its business enterprise ecology in tumor individual management and even more increasing to out-of-hospital market place. The out-of-medical center sector involves in depth on the internet and onsite retail pharmacies and personal establishments this sort of as personal hospitals and private clinics.

The Care Center presents all-time, all-situation, and detailed out-of-healthcare facility ailment administration products and services for hematologic tumor clients, such as 1) education and learning and specialist lectures to bolster patients’ self-management potential, 2) establishment of disease documents, individual observe-up, periodic well being and high-quality-of-lifetime assessment, treatment and subsequent check out reminder and the many others to enrich patients’ adherence to and self-confidence in treatment method, and 3) consultation hotline for quick facts ask for from individuals.  In addition, the Care Heart presents drug guidance, pathological examination, residual lesion assessment, and genetic tests for capable individuals, forming a services ecosystem for out-of-hospital client administration.

As of August 2021, Care Heart has cumulatively served practically 10,000 people with disorder like widespread hematological tumors (such as leukemia, lymphoma, and myeloma), and unusual hematological conditions (this sort of as myelodysplastic syndrome, myelofibrosis, Walden’s macroglobulinemia, and POEMS syndrome). Far more than 3,000 of physicians have furnished expert services for individuals through the electronic follow-up process on Zhongxin’s system. Medical professionals can look at just about every patient’s medicine documents, adverse reactions, subsequent visits, and assessment outcomes to observe patient’s problems and medication use and make customized recommendations to boost patient’s psychological and actual physical standing, patient’s self-confidence in procedure, and procedure success and safety.

According to Zhong Jin Qi Xin Global Consulting, the quantity of new conditions of hematologic tumors in China is expected to achieve 222,000 by 2024, and 247,000 by 2030. Zhongchao’s Treatment Center will be equipped to guide hematological tumor sufferers in resolving concerns all through cure and increasing actual physical restoration. Zhongchao aims to faucet the likely big hematological tumor market and is usually unwavering in its motivation to increasing scarce condition patients’ cure encounter by way of its individual management services.

About Zhongchao Inc.

Included in 2012 with headquarter offices in Shanghai and Beijing, China, Zhongchao Inc. is a platform-dependent net technologies organization.  It provides on the net healthcare details, experienced instruction and educational expert services to health care professionals underneath its “MDMOOC” system (www.mdmooc.org) and to the general public less than its “Sunshine Overall health Discussion boards” system (www.ygjkclass.com) in China. By means of its subsidiaries, the Firm also operates a platform featuring patient management products and services. Extra info about the Firm can be identified at its trader relations web page at http://izcmd.com.

Harmless Harbor Assertion

This press launch is made up of ahead-wanting statements as described by the Personal Securities Litigation Reform Act of 1995. Forward-looking statements include statements relating to strategies, targets, ambitions, methods, potential events or general performance, and fundamental assumptions and other statements that are other than statements of historic points. When the Company uses terms these kinds of as “might, “will, “intend,” “should,” “imagine,” “anticipate,” “anticipate,” “project,” “estimate” or similar expressions that do not relate entirely to historic issues, it is building ahead-looking statements. Forward-on the lookout statements are not assures of upcoming overall performance and involve dangers and uncertainties that may possibly induce the real final results to differ materially from the Firm’s expectations discussed in the ahead-looking statements. These statements are matter to uncertainties and dangers like, but not confined to, the pursuing:  the Company’s aims and strategies the Company’s future small business advancement product or service and services need and acceptance adjustments in technological know-how economic conditions the expansion of the specialist teaching and educational expert services market place in China and the other intercontinental marketplaces the Enterprise ideas to serve status and brand the effect of competitors and pricing government restrictions fluctuations in general financial and enterprise situations in China and the intercontinental markets the Company strategies to serve and assumptions underlying or similar to any of the foregoing and other risks contained in reviews filed by the Organization with the SEC, the size and severity of the recent coronavirus outbreak, including its impacts across our company and functions.  For these explanations, among some others, investors are cautioned not to spot undue reliance upon any ahead-searching statements in this press launch. Extra components are talked over in the Firm’s filings with the SEC, which are accessible for overview at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect gatherings or situations that arise right after the day hereof.

For far more details, make sure you get in touch with:

At the Enterprise: Pei Xu, CFO
E-mail: [email protected]
Cellphone: +86 21-3220-5987

Trader Relations: Sherry Zheng  
Weitian Group LLC
E-mail: [email protected]  
Phone: +1 718-213-7386

Source Zhongchao Inc.